Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates

Richard R. Barakat, Wei Wei Li, Christopher Lovelace, Joseph Bertino

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

The causes of intrinsic of intrinsic MTX resistance in four human cervical squamous cell carcinoma cell lines (SiHa, C-33A, ME-180, C-4I) with different sensitivities to methotrexate (MTX) were determined. The in situ or whole- cell assay for thymidylate synthase (TS) was used to screen for known causes of MTX resistance, including increased dihydrofolate reductase (DHFR), altered DHFR, impaired MTX uptake, and decreased formation of MTX polyglutamates. While all four cell lines displayed initial sensitivity to MTX as demonstrated by a TS activity of <20% following a 3-hr incubation with MTX, TS activity recovered in three of the four cell lines following a 4-hr incubation in drug-free media. Determination of MTX-polyglutamate accumulation in the four cell lines following a 24-hr incubation with 10 μM [3H]MTX revealed that a higher total intracellular level of MTX polyglutamates was achieved in the sensitive cell line (SiHa), with 54% occurring as long-chain tri-, tetra-, or pentaglutamates. The three resistant cell lines were found to contain less total MTX polyglutamates, with only 38, 14, and 13% occurring as long-chain MTX polyglutamates. Intrinsic MTX resistance in some cervical squamous cell carcinoma cell lines appears to be associated with a diminished accumulation of long-chain MTX polyglutamates, which are preferentially retained intracellularly.

Original languageEnglish (US)
Pages (from-to)54-60
Number of pages7
JournalGynecologic Oncology
Volume51
Issue number1
DOIs
StatePublished - Jan 1 1993

Fingerprint

Methotrexate
Squamous Cell Carcinoma
Cell Line
Thymidylate Synthase
Tetrahydrofolate Dehydrogenase
methotrexate polyglutamate
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Oncology
  • Obstetrics and Gynecology

Cite this

@article{c5e9960dd77844f39419bdb80955a1d7,
title = "Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates",
abstract = "The causes of intrinsic of intrinsic MTX resistance in four human cervical squamous cell carcinoma cell lines (SiHa, C-33A, ME-180, C-4I) with different sensitivities to methotrexate (MTX) were determined. The in situ or whole- cell assay for thymidylate synthase (TS) was used to screen for known causes of MTX resistance, including increased dihydrofolate reductase (DHFR), altered DHFR, impaired MTX uptake, and decreased formation of MTX polyglutamates. While all four cell lines displayed initial sensitivity to MTX as demonstrated by a TS activity of <20{\%} following a 3-hr incubation with MTX, TS activity recovered in three of the four cell lines following a 4-hr incubation in drug-free media. Determination of MTX-polyglutamate accumulation in the four cell lines following a 24-hr incubation with 10 μM [3H]MTX revealed that a higher total intracellular level of MTX polyglutamates was achieved in the sensitive cell line (SiHa), with 54{\%} occurring as long-chain tri-, tetra-, or pentaglutamates. The three resistant cell lines were found to contain less total MTX polyglutamates, with only 38, 14, and 13{\%} occurring as long-chain MTX polyglutamates. Intrinsic MTX resistance in some cervical squamous cell carcinoma cell lines appears to be associated with a diminished accumulation of long-chain MTX polyglutamates, which are preferentially retained intracellularly.",
author = "Barakat, {Richard R.} and Li, {Wei Wei} and Christopher Lovelace and Joseph Bertino",
year = "1993",
month = "1",
day = "1",
doi = "10.1006/gyno.1993.1246",
language = "English (US)",
volume = "51",
pages = "54--60",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates. / Barakat, Richard R.; Li, Wei Wei; Lovelace, Christopher; Bertino, Joseph.

In: Gynecologic Oncology, Vol. 51, No. 1, 01.01.1993, p. 54-60.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Intrinsic resistance of cervical squamous cell carcinoma cell lines to methotrexate (MTX) as a result of decreased accumulation of intracellular MTX polyglutamates

AU - Barakat, Richard R.

AU - Li, Wei Wei

AU - Lovelace, Christopher

AU - Bertino, Joseph

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The causes of intrinsic of intrinsic MTX resistance in four human cervical squamous cell carcinoma cell lines (SiHa, C-33A, ME-180, C-4I) with different sensitivities to methotrexate (MTX) were determined. The in situ or whole- cell assay for thymidylate synthase (TS) was used to screen for known causes of MTX resistance, including increased dihydrofolate reductase (DHFR), altered DHFR, impaired MTX uptake, and decreased formation of MTX polyglutamates. While all four cell lines displayed initial sensitivity to MTX as demonstrated by a TS activity of <20% following a 3-hr incubation with MTX, TS activity recovered in three of the four cell lines following a 4-hr incubation in drug-free media. Determination of MTX-polyglutamate accumulation in the four cell lines following a 24-hr incubation with 10 μM [3H]MTX revealed that a higher total intracellular level of MTX polyglutamates was achieved in the sensitive cell line (SiHa), with 54% occurring as long-chain tri-, tetra-, or pentaglutamates. The three resistant cell lines were found to contain less total MTX polyglutamates, with only 38, 14, and 13% occurring as long-chain MTX polyglutamates. Intrinsic MTX resistance in some cervical squamous cell carcinoma cell lines appears to be associated with a diminished accumulation of long-chain MTX polyglutamates, which are preferentially retained intracellularly.

AB - The causes of intrinsic of intrinsic MTX resistance in four human cervical squamous cell carcinoma cell lines (SiHa, C-33A, ME-180, C-4I) with different sensitivities to methotrexate (MTX) were determined. The in situ or whole- cell assay for thymidylate synthase (TS) was used to screen for known causes of MTX resistance, including increased dihydrofolate reductase (DHFR), altered DHFR, impaired MTX uptake, and decreased formation of MTX polyglutamates. While all four cell lines displayed initial sensitivity to MTX as demonstrated by a TS activity of <20% following a 3-hr incubation with MTX, TS activity recovered in three of the four cell lines following a 4-hr incubation in drug-free media. Determination of MTX-polyglutamate accumulation in the four cell lines following a 24-hr incubation with 10 μM [3H]MTX revealed that a higher total intracellular level of MTX polyglutamates was achieved in the sensitive cell line (SiHa), with 54% occurring as long-chain tri-, tetra-, or pentaglutamates. The three resistant cell lines were found to contain less total MTX polyglutamates, with only 38, 14, and 13% occurring as long-chain MTX polyglutamates. Intrinsic MTX resistance in some cervical squamous cell carcinoma cell lines appears to be associated with a diminished accumulation of long-chain MTX polyglutamates, which are preferentially retained intracellularly.

UR - http://www.scopus.com/inward/record.url?scp=0027381587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027381587&partnerID=8YFLogxK

U2 - 10.1006/gyno.1993.1246

DO - 10.1006/gyno.1993.1246

M3 - Article

C2 - 7694891

AN - SCOPUS:0027381587

VL - 51

SP - 54

EP - 60

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -